CLINICAL_TRIALS
trial_result
· 2026-04-23
Clinical Trial Update: Trial of Pembrolizumab and Radiotherapy in Melanoma [Phase 2]
Summary
A Phase 2 trial evaluating pembrolizumab in combination with radiotherapy for melanoma has been terminated, with results posted on 2026-04-23.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2026-04-23